ANIK
Anika Therapeutics Inc.
Company Overview
| Mkt Cap | $140.43M | Price | $9.82 |
| Volume | 83.86K | Change | +0.72% |
| P/E Ratio | -2.5 | Open | $9.79 |
| Revenue | $119.9M | Prev Close | $9.75 |
| Net Income | $-56.4M | 52W Range | $7.87 - $18.37 |
| Div Yield | N/A | Target | $18.33 |
| Overall | 51 | Value | 60 |
| Quality | 50 | Technical | 45 |
No chart data available
Stock Overview
Updated DailyAnika Therapeutics Inc. (ANIK) is a leading Healthcare company in the Biotechnology industry, currently trading at $9.75 with a market capitalization of $140.43 million. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating average quality indicators with a MarketXLS quality score of 50.
Today's trading session shows ANIK with a volume of 57K shares. The stock opened down 0.61% from yesterday's close of $9.78. Current analyst estimates project earnings of $-0.94 per share for this year, with next year targeting $-0.74.
ANIK demonstrates weak technical indicators based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including MDT, DYNT, SYK, JNJ, HALO.
Key investment considerations for ANIK include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 88.0%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 07:48 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ANIK | $9.82 | +0.7% | 83.86K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |